Structural insights for selective disruption of Beclin 1 binding to Bcl-2
Abstract Stimulation of autophagy could provide powerful therapies for multiple diseases, including cancer and neurodegeneration. An attractive drug target for this purpose is Bcl-2, which inhibits autophagy by binding to the Beclin 1 BH3-domain. However, compounds that preclude Beclin 1/Bcl-2 bindi...
Main Authors: | Yun-Zu Pan, Qiren Liang, Diana R. Tomchick, Jef K. De Brabander, Josep Rizo |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-10-01
|
Series: | Communications Biology |
Online Access: | https://doi.org/10.1038/s42003-023-05467-w |
Similar Items
-
Regulation of the Autophagic Bcl-2/Beclin 1 Interaction
by: Geert Bultynck, et al.
Published: (2012-07-01) -
Impaired Autophagy in Krabbe Disease: The Role of BCL2 and Beclin-1 Phosphorylation
by: Nadia Papini, et al.
Published: (2023-03-01) -
Differential dependence on Beclin 1 for the regulation of pro-survival autophagy by Bcl-2 and Bcl-xL in HCT116 colorectal cancer cells.
by: Muriel Priault, et al.
Published: (2010-01-01) -
Mechanistic insights into neurotransmitter release and presynaptic plasticity from the crystal structure of Munc13-1 C1C2BMUN
by: Junjie Xu, et al.
Published: (2017-02-01) -
Decreased expression of Beclin 1 correlates closely with Bcl-xL expression and poor prognosis of ovarian carcinoma.
by: Huan-Xin Lin, et al.
Published: (2013-01-01)